New Cousteau-Linked...
Health Care: Drugs
Anika Therapeutics Inc. (ANIK: NASDAQ)
$13.01 -0.59 | -4.34%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 35.78M | 28.20M | 24.43M | 43.19M |
| Receivables | 17.31M | 14.82M | 11.83M | 5.42M |
| Inventories | 7.30M | 8.95M | 8.44M | 5.52M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 64.14M | 56.32M | 49.80M | 55.83M |
| Property, Plant & Equipment, Gross | 50.85M | 49.70M | 47.17M | 42.44M |
| Accumulated Depreciation & Depletion | 14.38M | 12.72M | 11.42M | 10.19M |
| Property, Plant & Equipment, Net | 36.47M | 36.98M | 35.75M | 32.25M |
| Intangibles | 23.15M | 25.76M | 33.58M | 936.28K |
| Other Non-Current Assets | 205.04K | 384.99K | 413.23K | 506.79K |
| Total Non-Current Assets | 68.71M | 72.61M | 80.90M | 39.99M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 132.84M | 128.94M | 130.70M | 95.82M |
| Accounts Payable | 4.30M | 9.69M | 6.37M | 2.38M |
| Short Term Debt | 1.60M | 1.60M | 1.60M | 1.60M |
| Other Current Liabilities | 450.48K | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 14.54M | 19.37M | 16.53M | 9.03M |
| Long Term Debt | 9.60M | 11.20M | 12.80M | 0.00 |
| Deferred Income Taxes | 7.38M | 6.22M | 9.31M | 0.00 |
| Other Non-Current Liabilities | 6.57M | 6.96M | 9.92M | 26.03M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 23.54M | 24.38M | 32.02M | 26.03M |
| Total Liabilities | 38.08M | 43.75M | 48.56M | 35.06M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 94.76M | 85.19M | 82.14M | 60.76M |
| Common Par | 136.30K | 134.82K | 134.19K | 113.78K |
| Additional Paid In Capital | 63.44M | 61.82M | 60.54M | 42.86M |
| Cumulative Translation Adjustment | -3.07M | -2.55M | 0.00 | 0.00 |
| Retained Earnings | 34.25M | 25.79M | 21.47M | 17.78M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 104.36M | 96.39M | 94.94M | 60.76M |
| Total Equity | 94.76M | 85.19M | 82.14M | 60.76M |
| Total Liabilities & Stock Equity | 132.84M | 128.94M | 130.70M | 95.82M |
| Total Common Shares Outstanding | 13.63M | 13.48M | 13.42M | 11.38M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 13.06M | 12.62M | 11.39M | 11.31M |
| Diluted Weighted Shares Outstanding | 13.75M | 13.65M | 11.56M | 11.46M |
| Number of Employees | 129 | 114 | 133 | 84 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ANIK
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- UserTrade Growth
- Userbfab Portfolio 1
- Usersome mad buggers wall
- Usermjaquillard Portfolio 1
- UserJenaLoren Stocks
- Usermagic formula cws
- UserLittle Nicky's Pop
Latest ANIK Headlines from TheStreet
- Anika Therapeutics' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.04.12 | 12:05 pm
- 8 Stocks Rising on Unusual Volume 04.09.12 | 01:04 pm
- 8 Stocks Rising on Monster Volume 04.02.12 | 01:04 pm
- 8 Stocks Rising on Monster Volume 03.21.12 | 02:03 pm
- Anika Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.01.12 | 06:03 pm
- Anika Therapeutics Inc. Stock Upgraded (ANIK) 11.15.11 | 06:11 am
- Anika Therapeutics' CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.03.11 | 02:11 pm
- Anika Stock Soars (ANIK) 11.03.11 | 09:11 am
- Anika Therapeutics CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.05.11 | 02:08 pm
- Anika Therapeutics Inc. Stock Downgraded (ANIK) 05.09.11 | 08:05 am
Press Releases for ANIK
- Anika Therapeutics Announces Date Of First-Quarter 2012 Financial Results Conference Call - Business Wire 04.26.12 | 08:04 am
- Anika Therapeutics Reports 25% Increase In Fourth-Quarter Revenue - Business Wire 02.29.12 | 05:02 pm
- Anika Therapeutics Announces Date Of Fourth-Quarter And Year-End 2011 Financial Results Conference Call - Business Wire 02.23.12 | 09:02 am
- Anika Therapeutics To Present At The Canaccord Genuity Musculoskeletal Conference On February 7 - Business Wire 02.02.12 | 01:02 pm
- Anika Therapeutics To Present At The Eighth Annual Noble Financial Equity Conference On January 17 - Business Wire 01.10.12 | 10:01 am
- Anika Therapeutics Announces U.S. MONOVISC® License And Supply Agreement With DePuy Mitek, Inc. - Business Wire 12.21.11 | 03:12 pm
- Anika Therapeutics To Present At The LD Micro Conference On December 8 - Business Wire 11.30.11 | 11:11 am
- Anika Therapeutics To Present At The Security Research Associates 7th Annual Fall Growth Stock Conference On November 15 - PR Newswire 11.15.11 | 08:11 am
- Anika Therapeutics To Present At The Security Research Associates 7th Annual Fall Growth Stock Conference On November 15 - PR Newswire 11.10.11 | 08:11 am
- Anika Therapeutics Reports 33% Revenue Growth In Third Quarter 2011 - Business Wire 11.02.11 | 04:11 pm
Partner Headlines for ANIK
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 05.30.12 | 09:05 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 05.25.12 | 09:05 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 05.23.12 | 09:05 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 05.17.12 | 09:05 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 05.10.12 | 09:05 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 05.08.12 | 09:05 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 04.25.12 | 09:04 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 04.20.12 | 09:04 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 04.16.12 | 09:04 am
- Two Stocks Crossing Over Their 50 Day Moving Averages (ANIK, EKB) - Benzinga 11.30.10 | 01:11 pm
